Dr. Nicholas T Potter has been appointed to the Medical Advisory Board of Epigenomics AG, a molecular diagnostics company developing and commercializing tests for the screening and diagnosis of cancer. Their lead product Epi…
Read more
In 2011, an estimated 230,480 new cases of invasive breast cancer will be diagnosed among women in the United States, and an estimated 57,650 cases of in situ breast cancer will be detected. To educate the public about breast cancer and the best ways…
Read more
Drs. Neil Quigley and Nicholas Potter co-authored a recent article comparing two assays' detection rate of the human papillomavirus (HPV) in women 30 years of age and older.
The objective of the study was to estimate high-risk (HR) HPV…
Read more